FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

“Receiving the Fast Track Designation for AJ201 marks a significant milestone for AnnJi,” said Dr. Wendy Huang, CEO and Chairperson of the Board of AnnJi.